Mankind Pharma Ltd

  • BSE Code : 543904
  • NSE Symbol : MANKIND
  • ISIN : INE634S01028
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 2,652.30 13.00(0.49%)

Open Price ()

2,640.00

Prev. Close ()

2,639.30

Volume (No’s)

421,325

Market Cap ()

109,468.05

Low Price ()

2,627.00

High Price ()

2,668.90

 

Board Meetings

Start Date End Date Purpose
14-Jul-2025 31-Jul-2025 Quarterly Results & Interim Dividend Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 & 50 of the Listing Regulations, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, July 31, 2025, inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30, 2025; and declaration of interim dividend, if any, for the financial year 2025-26. (As Per BSE Announcement dated on 14.07.2025)
08-May-2025 21-May-2025 Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2025 inter alia to consider and approve Pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday May 21 2025 inter-alia to consider and approve the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31 2025. Further in continuation of our earlier letter dated March 26 2025 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading the trading window for trading in the securities of the Company shall remain closed till May 23 2025 Outcome of Board Meeting (As Per BSE Announcement Dated on: 21/05/2025)
14-Apr-2025 14-Apr-2025 Outcome of Board Meeting held on April 14, 2025
13-Jan-2025 23-Jan-2025 Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on December 31 2024. Outcome of Board Meeting held today i.e. January 23, 2025. (As Per BSE Announcement dated on 23.01.2025)
08-Jan-2025 08-Jan-2025 Outcome of the Board Meeting held today i.e. January 8, 2025.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew